This approach is supported by experiments in a breast cancer xenograft model showing that intratumoral injections of an antibody to Nectin-4 can stall tumor growth in vivo by disrupting cell–cell contacts [18]. This evidence concerns the gene NECTIN4 and breast carcinoma.